PHK
ACHN

Point72 Hong Kong’s Achillion Pharmaceuticals ACHN Stock Holding History

Point72 Hong Kong’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,370
Closed -$9K – 1583
2019
Q3 		$9K Buy
+2,370
New +$9.14K ﹤0.01% 774
2019
Q1 		– Sell
-14,257
Closed -$23K – 1399
2018
Q4 		$23K Buy
+14,257
New +$40.3K 0.01% 437
2018
Q3 		– Sell
-680
Closed -$2K – 1331
2018
Q2 		$2K Buy
+680
New +$2.32K ﹤0.01% 805
2018
Q1 		– Sell
-2,865
Closed -$8K – 1267
2017
Q4 		$8K Buy
+2,865
New +$10.4K 0.01% 534

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Hong Kong's ACHN Position: Q4 2019 in Review

Point72 Hong Kong sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 2,370 shares — an estimated $9K sold.

Point72 Hong Kong first reported a position in ACHN in Q4 2017 and held it in 4 quarters. The position peaked at $23K in Q4 2018. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Point72 Hong Kong reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Point72 Hong Kong sold 2,370 Achillion Pharmaceuticals shares in Q4 2019, an estimated $9K.
  • Point72 Hong Kong first reported a position in Achillion Pharmaceuticals in Q4 2017 and held it in 4 quarters.
  • Point72 Hong Kong's Achillion Pharmaceuticals position peaked at $23K in Q4 2018.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Point72 Hong Kong's 13F filing for Q4 2019, filed 14 Feb 2020.